首页> 外文期刊>EFSA Journal >Opinion on the re‐evaluation of starch sodium octenyl succinate (E 1450) as a food additive in foods for infants below 16 weeks of age and the follow‐up of its re‐evaluation as a food additive for uses in foods for all population groups
【24h】

Opinion on the re‐evaluation of starch sodium octenyl succinate (E 1450) as a food additive in foods for infants below 16 weeks of age and the follow‐up of its re‐evaluation as a food additive for uses in foods for all population groups

机译:关于在16周龄的婴儿食品中作为食物添加剂重新评估淀粉钠叔丁基酸钠(E 1450)的意见,并将其再评估作为所有人口群体用于食物的食品添加剂的后续

获取原文
       

摘要

As a follow‐up to the re‐evaluation of starch sodium octenyl succinate (SSOS; E 1450), the Panel on Food Additives and Flavourings (FAF) was requested to assess the safety of SSOS (E 1450) when used in food for infants below 16 weeks of age for food categories 13.1.5.1 and 13.1.1 and to address the data gaps identified during the re‐evaluation of the SSOS (E 1450). The process involved the publication of a call for data. The Panel considered it feasible to amend the specifications based on the analytical evidence submitted. In the call for data, clinical trials were submitted to support the safe use in this age group. In addition, the report of a postnatal piglet study was provided. Due to the low internal validity of the clinical studies, the Panel concluded that a reference point could not be derived from them. The Panel noted that the uncertainty surrounding the results of the piglet study precludes deriving a reference point from this study. On the other hand, both data sources did not clearly indicate an adverse effect due to SSOS (E 1450). Given the available data, the Panel concluded that at use levels of SSOS in food for infants below 16 weeks within the range reported in the clinical studies (up to 2,725 mg/kg body weight (bw) per day), there is no indication for safety concern and reiterated the conclusion of the Panel on Food Additives and Nutrient Sources added to Food (ANS) that there was no need for a numerical acceptable daily intake (ADI). When extrapolating this conclusion to the safety assessment of the food additive when used in food categories (FCs) 13.1.5.1 and 13.1.5.2 in food for infants above 16 weeks of age and young children, the Panel considered that there is no indication for safety concern also for these uses within the range reported in the clinical studies.
机译:作为淀粉钠琥珀酸钠(SSOS; e 1450)重新评估的后续评价,要求食品添加剂和调味料(FAF)的小组评估SSOS(E 1450)的安全性,用于婴儿的食物食品类别低于16周的食物类别13.1.5.1和13.1.1,并解决了在SSO的重新评估期间确定的数据差距(E 1450)。该过程涉及发布数据的呼叫。小组认为根据提交的分析证据修改规范是可行的。在对数据的呼吁中,提交了临床试验,以支持该年龄组安全使用。此外,还提供了出生后仔猪研究的报告。由于临床研究的内部有效性较低,小组得出结论,参考点无法源自它们。小组指出,周围仔猪研究结果的不确定性排除了来自该研究的参考点。另一方面,由于SSO(E 1450),两个数据源都没有明确表示不利影响。鉴于可用数据,小组得出结论,在临​​床研究中报告的范围内婴儿在16周内使用婴儿的SSOS的SSO水平(每天高达2,725 mg / kg体重(BW)),没有迹象安全问题并重申了粮食添加剂和营养源的结论,添加到食品(ANS)中,没有必要进行数值可接受的每日摄入(ADI)。当在食品类别(FCS)中用于食品类别(FCS)的安全评估时将该结论推断为13.1.5.1和13.1.5.2在16周龄和幼儿的食品中,该小组认为没有迹象表明安全对于临床研究报告的范围内,也关注这些用途。

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号